🌱 KidneyEnergy.com

← brief for 2026-10-20 · Slowing decline

The pharmacokinetics of a single intravenous dose of difelikefalin in adolescents aged 12 to 17 years on hemodialysis

Article B Peer reviewed Small trial

Key takeaways

This small study gave a single dose of a scratch-control drug to teens on dialysis. It tracked how the drug moved through their bodies over three days. The goal was to check safety and how the body handles the medicine.

Who did this work

Chebl C. Mourani (Saint Joseph University) · Amrit Pal Kaur (Royal Manchester Children's Hospital) · Pauline Abou Jaoudeh (Saint George Hospital) · B. C. Reynolds (Royal Hospital for Children) · Isabelle Morin (Vifor Pharma (Switzerland)) · Milica Enoiu (Vifor Pharma (Switzerland))

Source

Article · OpenAlex, CKD works · 2026-10-19
https://doi.org/10.1007/s00467-026-07561-7